Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Buddy: Sidley's nets will be cast well beyond Aaro

Message Board Public Reply | Private Reply | Keep | Replies (3)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154852
(Total Views: 1016)
Posted On: 02/21/2022 2:47:12 PM
Posted By: Jake2212
Re: Buddyboy20 #118796
Buddy: Sidley's nets will be cast well beyond Aaron's toss. I don't quarrel with his assessment that willful malfeasance is difficult to prove compared to gross negligence or that he has accurately referenced section 9.3 of the Master Agreement between CYDY and Amarex. So I concur that proof by a preponderance of the evidence (more likely than not) that Amarex employees were grossly negligent in submitting the HIV BLA will allow CYDY to recover compensatory damages for lost profits if causation can also be established. In this setting, causation would likely require evidence demonstrating that a competently submitted application would more likely than not have been approved by the FDA and that the subsequent marketing of LL would more likely than not have generated profits within a given range to a reasonable degree of economic certainty.

Accomplishing all of the above would clearly be a tall task for Sidley. Success, however, would likely result in a jury verdict for hundreds of millions of dollars, and if the preponderance of the evidence also showed that NSF had exerted sufficient control over the submission of the BLA or that it had agreed to indemnify Amarex's creditors, NSF would be jointly liable for those damages.

Notwithstanding, however, the worthiness of pursuing the gross negligence scenario, I would expect Sidley to laser focus on the potential to prove willful malfeasance. If the evidence supported a jury finding of willful malfeasance that would bring punitive damages into play in addition to the potentially heavy compensatory damages referenced above.

As best as I've been able to determine, based on a brief search of Maryland law re punitive damages: Amarex, and possibly NSF if the control factor were to be met, could be found liable for punitive damages to punish egregiously bad behavior and to deter others from contemplating similar behavior if the jury were to find by clear and convincing evidence that defendant(s) acted with actual malice (a legal synonym for willful malfeasance). The awarding of compensatory damages (with the daunting causation element) would be a prerequisite to punitive damages, and the amount of the punitive damages would have to be proportionate to the defendant(s) ability to pay (net worth). Accordingly, only NSF would likely be a candidate for punitive damages since the compensatory damages alone would likely sink Amarex.

I believe that the scenario laid out above is plausible, but since I have no way of knowing what evidence Sidley will find as it pursues the accounting, my scenario should be regarded as highly speculative. It would require the discovery of damning evidence, and I have no idea if such evidence exists, let alone that Sidley will be able to find it. But I have little doubt that this is the type of evidence that Sidley will be seeking.

A final note: a successful outcome to a jury trial, followed by post trial motions, and the subsequent appeal would take many years. If Sidley were to find evidence of actual malice and the requisite control by NSF, the likely result would be a pre suit or pre trial settlement. And given the financial exposure to NSF if damning evidence and the control factor were. to be in play, Sidley would have enormous leverage during those negotiations. I think we'd all be quite happy with the result.


(24)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us